White N J, Looareesuwan S, Warrell D A
J Cardiovasc Pharmacol. 1983 Mar-Apr;5(2):173-5. doi: 10.1097/00005344-198303000-00001.
We recorded electrocardiograms from 31 patients receiving quinine and 14 patients receiving quinidine for the treatment of Plasmodium falciparum malaria. Despite plasma quinine concentrations of up to 20 mg/L, there was no evidence of cardiotoxicity. QT prolongation was considerably greater in the quinidine-treated patients. The mean ratio of change in corrected QT interval to change in plasma concentration (delta QTc%/delta CQ) was 3.2% . mg-1 . L-1 for quinidine, compared to 0.74% . mg-1 . L-1 for quinine (p less than 0.001). T-wave flattening was observed in both groups. Plasma concentrations of quinine cannot be predicted from the EKG, because concentrations within the therapeutic range produced only minor and unpredictable abnormalities.
我们记录了31例接受奎宁治疗和14例接受奎尼丁治疗的恶性疟原虫疟疾患者的心电图。尽管血浆奎宁浓度高达20mg/L,但未发现心脏毒性证据。奎尼丁治疗的患者QT间期延长更为明显。校正QT间期变化与血浆浓度变化的平均比值(delta QTc%/delta CQ),奎尼丁为3.2%·mg⁻¹·L⁻¹,而奎宁为0.74%·mg⁻¹·L⁻¹(p<0.001)。两组均观察到T波低平。心电图无法预测血浆奎宁浓度,因为治疗范围内的浓度仅产生轻微且不可预测的异常。